Specific Responsibilities of the Parties Sample Clauses
The 'Specific Responsibilities of the Parties' clause defines the particular duties and obligations that each party must fulfill under the agreement. It typically outlines who is responsible for providing certain services, delivering goods, maintaining communication, or meeting deadlines, and may specify standards or procedures to be followed. By clearly delineating these responsibilities, the clause helps prevent misunderstandings and disputes by ensuring that all parties know exactly what is expected of them.
Specific Responsibilities of the Parties. 1. The Parties shall cooperate fully with the IPTF and shall so instruct all their law enforcement agencies.
2. Within 30 days after this Agreement enters into force, the Parties shall provide the IPTF Commissioner or his or her designee with information on their law enforcement agencies, including their size, location, and force structure. Upon request of the IPTF Commissioner, they shall provide additional information, including any training, operational, or employment and service records of law enforcement agencies and personnel.
3. The Parties shall not impede the movement of IPTF personnel or in any way hinder, obstruct, or delay them in the performance of their responsibilities. They shall allow IPTF personnel immediate and complete access to any site, person, activity, proceeding, record, or other item or event in Bosnia and Herzegovina as requested by the IPTF in carrying out its responsibilities under this Agreement. This shall include the right to monitor, observe, and inspect any site or facility at which it believes that police, law enforcement, detention, or judicial activities are taking place.
4. Upon request by the IPTF, the Parties shall make available for training qualified personnel, who are expected to take up law enforcement duties immediately following such training.
5. The Parties shall facilitate the operations of the IPTF in Bosnia and Herzegovina, including by the provision of appropriate assistance as requested with regard to transportation, subsistence, accommodations, communications, and other facilities at rates equivalent to those provided for the IFOR under applicable agreements.
Specific Responsibilities of the Parties. 9.1 Specific Responsibilities of the County and Cities. The County and Cities shall undertake the following activities:
(a) Maintain the school concurrency provisions in their Land Development Regulations (LDR) consistent with the requirements of this Agreement.
(b) Withhold the approval of any Preliminary Development Request, or functional equivalent for new residential units not exempted under Section 13.1(d) of this Agreement, until the School Board has issued a CDL verifying that FISH Capacity is currently available to accommodate a residential project.
(c) Withhold the approval of any Final Development Request, or functional equivalent for new residential units not exempted under Section 13.1(d) of this Agreement, until the School Board has issued a SCADL verifying that FISH Capacity is available and has been reserved to accommodate a residential project.
(d) Share information with the School Board regarding population projections, projections of development and redevelopment for the next 10 years, infrastructure required to support public school facilities, and amendments to the Comprehensive Plan consistent with the requirements of this Agreement by October 15th of each year.
(e) Maintain data for approved new residential development. The data shall be provided to the School Board annually by October 15th, for the prior fiscal year (October 1 to September 30). and include at a minimum, the following:
1. Development name and location
2. Total number of dwelling units by unit type (single-family, multi-family, etc.) and any planned phasing information.
3. Impact fee calculation, from the jurisdiction collecting the fees.
4. Total number of dwelling units with certificates of occupancy (CO) by development or by remaining vacant lots per development.
5. A list of all Preliminary and Final Development Requests determined to be exempt based on de minimis impact.
6. A list of all expired projects and completed projects.
7. A list of any changes to the Comprehensive Plan in the Public School Facilities Element (if applicable), Intergovernmental Coordination Element, Capital Improvements Element, or any other element related to Public Schools.
(f) Transmit School Facility Planning and Concurrency Applications to the School Board to undertake the School Impact Analysis (SIA) for all residential Preliminary and Final Development Requests unless exempt under Section 13.1 (d) of this Agreement.
Specific Responsibilities of the Parties. 12
9.1 Specific Responsibilities of the County and Cities 12 9.2 Specific Responsibilities of the School Board 13
Specific Responsibilities of the Parties. (A) manufacturing, packaging and labeling GMP-grade quantities of the Conducting Party Compound(s), and packaging and labeling of the Combined Therapy for use in the Combined Therapy Trials, (B) packaging and labeling the vials, if applicable, provided by the Non-Conducting Party of the Non-Conducting Party Compound(s) for use in the Combined Therapy Trials, (C) providing the JDC with prompt notice of any Manufacturing and supply issues with respect to the Conducting Party’s Compound that may adversely impact the conduct or timelines of a Combined Therapy Trial, and (D) providing the Non-Conducting Party with clinical drug supply forecasts and drug delivery dates for the Non-Conducting Party Compound(s) (which shall be set forth more fully in the Supply Agreement); (ii) with the cooperation of the Non-Conducting Party, compiling, amending and filing all necessary Combined Therapy Trial Regulatory Documentation with Regulatory Authority(ies), maintaining and acting as the sponsor of record as provided in 21 CFR 312.50 (and applicable comparable ex-US laws) with responsibility, unless otherwise delegated in accordance with 21 CFR 312.52 (and applicable comparable ex-US laws), for each Combined Therapy Trial and making all required submissions to Regulatory Authorities related thereto on a timely basis; (iii) with Non-Conducting Party cooperation, and subject to the provisions of Section 9.6, listing any Combined Therapy Trial required to be listed on a public database on ▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ or other public registry in any country in which such Combined Therapy Trial is being conducted in accordance with Applicable Law and in accordance with each Party’s internal policies relating to clinical trial registration; (iv) providing the Non-Conducting Party with reasonable advance notice of scheduled meetings or other material non-written communications with a Regulatory Authority and the opportunity to participate in each such meeting (to the extent permitted by Applicable Law and such Regulatory Authority) or other non-written communication, to the extent that it relates to the conduct of the Combined Therapy Trial or the Non-Conducting Party Compound(s) and providing such opportunity to participate in such meetings (to the extent permitted by Applicable Law and such Regulatory Authority) to Ipsen (only for meetings with Regulatory Authorities in the Page 28 [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitt...
Specific Responsibilities of the Parties. Subject to the terms of this Agreement, each Party shall use Commercially Reasonable Efforts to (i) supply the quantities of its Compound as needed to conduct a Combined Therapy Study on a timely basis, and package and deliver same to Study Sites (or if such Party is the Other Party, to the Sponsoring Party’s labeling facility), in accordance with the time frame(s) established by the JDC and (ii) conduct and complete the Combined Therapy Study in accordance with the applicable Clinical Obligations Schedule. The Parties shall be responsible for activities for the conduct of each Combined Therapy Study as set forth below.
Specific Responsibilities of the Parties. Subject to the terms of this Agreement, each Party shall use Commercially Reasonable Efforts to (i) supply the quantities of its Compound as needed to conduct a Combined Therapy Trial on a timely basis, with BioXcel packaging, labeling and delivering same to study sites, in accordance with the time frame(s) established by the JDC; (ii) to conduct and complete each Combined Therapy Trial and any Statistical Analysis Plans and Bioanalysis Plans relating thereto on a timely basis in accordance with the Protocol, Bioanalysis Plans, Statistical Analysis Plans and Third Party agreements relating thereto, and (iii) to timely provide Rights of Cross-Reference where required by this Agreement. Each Party shall be responsible for activities assigned to it by the Protocol and/or JDC that such Party is not otherwise obligated to perform by this Agreement, provided that, except as set forth in this Agreement, in no event shall either Party be obligated to perform any such assigned activities without its prior written consent (which may be reflected in the minutes of meetings of the JDC or in the Protocol). As of the Effective Date, each Party shall be responsible for the following activities:
(a) Responsibilities of BioXcel. Subject to JDC direction and oversight as provided in Section 2.4 and BioXcel’s Commercially Reasonably Efforts, BioXcel shall be responsible for the following activities, subject in each case (except as expressly provided in Section 4.1(a) with respect to the Manufacture and supply of the BioXcel Compound) to the Parties sharing the applicable Third Party Study Costs related to such activities in accordance with Section 7.1:
(i) (A) Manufacturing, packaging and labeling the BioXcel Compound for use in the Combined Therapy Trials, (B) packaging and labeling the vials provided by Nektar of the Nektar Compound and vials provided by the CPI Compound supplier of the CPI Compound for use in the Combined Therapy Trials, and (C) providing the JDC (or a working team designated by the JDC) on a monthly basis with a clinical drug supply forecast for the Nektar Compound and CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WHERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. the CPI Compound and the BioXcel...
Specific Responsibilities of the Parties. A. DE-CoC Responsibilities The DE-CoC serves as the lead governance body for Delaware’s Continuum of Care (DE-500), providing oversight, project direction, policy setting, and guidance for HPC. The DE-CoC exercises all its responsibilities for CoC governance through its membership, effective as of the date of the authorization of this MOU. These responsibilities include:
Specific Responsibilities of the Parties. C1 the Client shall be responsible for:
Specific Responsibilities of the Parties. 6.1 MORPC will contribute Two Hundred Thousand and 00/100 U.S. Dollars ($200,000.00) of Federal Funds in compliance with U.S. DOT Guidelines in consideration of the City of Columbus, COTA, and the Contiguous Jurisdictions financially contributing to the Regional Corridor Analysis.
6.2 The City of Columbus will pay MORPC Two Hundred Thousand and 00/100 U.S. Dollars ($200,000.00) in consideration of MORPC procuring and managing the Regional Corridor Analysis.
6.3 COTA will pay MORPC One Hundred Thousand and 00/100 U.S. Dollars ($100,000.00) in consideration of MORPC procuring and managing the Regional Corridor Analysis.
6.4 The Contiguous Jurisdictions named above will together pay MORPC a total of Eighty-five Thousand and 00/100 U.S. Dollars ($85,000.00) as previously stated in individually submitted Letters of Commitment in consideration of MORPC procuring and managing the Regional Corridor Analysis.
6.5 MORPC will be the primary funder of this project and will hold the contract with the consultant. MORPC will manage the project in collaboration with all parties and a high-level steering committee.
6.6 MORPC will provide limited assistance to the consultant in the various tasks of the project scope as described in the Request for Proposals (RFP).
6.7 Additional funding partners may enter into this agreement by means of an amendment to this MOU.
Specific Responsibilities of the Parties. 9.1 Specific Responsibilities of the County and Cities. When the Comprehensive Plan amendments adopted in accordance with Section 11 of this Agreement become effective, theThe County and Cities shall undertake the following activities:
(a) AdoptMaintain the required school concurrency provisions intoin their Land Development Regulations (LDR) consistent with the time frame established by law, the requirements of this Agreement, and the County and Cities’ comprehensive plans, unless electing to be bound by the provisions established by the County.
(b) Withhold the approval of any rezoning, site plan, preliminary platPreliminary Development Request, or functional equivalent for new residential units not exempted under Section 13.1(cd) of this Agreement, until the School DistrictBoard has reportedissued a CDL verifying that thereFISH Capacity is school capacitycurrently available to serve the development being approved consistent with the requirementsaccommodate a residential project.